PT Diastika Biotekindo Tbk (IDX:CHEK)
Indonesia · Delayed Price · Currency is IDR
139.00
0.00 (0.00%)
At close: Apr 28, 2026
Revenue by Segment
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
|---|
| 59.45B | 37.81B | 20.95B | 16.80B |
Life Science Group Growth | 57.24% | 80.46% | 24.68% | - |
Clinical Diagnostic Group | 141.86B | 116.98B | 108.15B | 100.67B |
Clinical Diagnostic Group Growth | 21.26% | 8.17% | 7.43% | - |
| 201.31B | 154.79B | 129.10B | 117.47B |
| 30.05% | 19.90% | 9.90% | - |
Revenue by Geography
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
|---|
| 201.31B | 154.79B | 129.10B | 117.47B |
| 30.05% | 19.90% | 9.90% | - |
| 201.31B | 154.79B | 129.10B | 117.47B |
| 30.05% | 19.90% | 9.90% | - |
Source: S&P Global Market Intelligence.
